The Atara Biotherapeutics, Inc. (ATRA) EVP Christopher Haqq Sells 6000 Shares

Xavier Trudeau
Juillet 21, 2017

This indicates more upside for the $38.98 billion company. 147,619 shares of the stock were exchanged. Constellation Brands, Inc. (NYSE:STZ) has risen 17.20% since July 17, 2016 and is uptrending. It has outperformed by 129.04% the S&P500. Atara Biotherapeutics, Inc. has a 1-year low of $11.80 and a 1-year high of $25.73.

State Board of Administration of Florida Retirement System held its stake in shares of Atara Biotherapeutics, Inc. Morgan Stanley controls 746 shares worth $15,000.

Atara Biotherapeutics Inc now has $465.29M valuation. About 173,625 shares traded. About 188,781 shares traded. Soffer Gad also sold $220,144 worth of Atara Biotherapeutics Inc (NASDAQ:ATRA) on Tuesday, February 14. It has underperformed by 23.98% the S&P500.

Investors sentiment increased to 1.86 in 2016 Q4. Its up 0.38, from 1.48 in 2016Q3. It fall, as 55 investors sold CVX shares while 689 reduced holdings. Finally, Vident Investment Advisory LLC increased its stake in Atara Biotherapeutics by 41.8% in the fourth quarter. The stock increased 4.65% or $0.7 during the last trading session, reaching $15.75. Capstone Advsrs Ltd Llc accumulated 37,641 shares or 0.14% of the stock. Nomura accumulated 0% or 17,100 shares. Atara Biotherapeutics earned a media sentiment score of 0.25 on Accern's scale. The value of the investment in ATRA went from $3,065,000 to $8,935,000 increasing 191.5% for the reporting period. The Wisconsin-based Northern Capital Management Llc has invested 0.72% in the stock. The Kansas-based Creative Planning has invested 0% in Atara Biotherapeutics Inc (NASDAQ:ATRA). Teachers Advisors LLC increased its stake in shares of Atara Biotherapeutics by 5.5% in the fourth quarter. 5,994 are owned by Blackrock Group Inc Limited. Harbourvest Partners Lc holds 0.09% or 10,543 shares in its portfolio. Voya Mgmt Limited Company invested in 21,052 shares. Proshare Limited Co reported 22,796 shares. Zacks Investment Research raised shares of Atara Biotherapeutics from a "sell" rating to a "hold" rating in a research report on Tuesday, June 27th. Therefore 67% are positive.

Equities analysts forecast that Atara Biotherapeutics, Inc. The rating was initiated by William Blair with "Outperform" on Friday, October 9. As per Friday, September 25, the company rating was initiated by JMP Securities. Brown Brothers Harriman And reported 126 shares. The rating was downgraded by Goldman Sachs on Tuesday, October 11 to "Sell".

Artal Group Sa decreased Avexis Inc stake by 50,000 shares to 150,000 valued at $7.16M in 2016Q4. Acceleron Pharma Inc (NASDAQ:XLRN) was reduced too.

Since February 2, 2017, it had 0 buys, and 26 sales for $3.86 million activity. (ATRA) opened at 16.00 on Thursday. The insider MCGRATH JOHN sold $60,440. Also, EVP Christopher Haqq sold 6,000 shares of the firm's stock in a transaction on Monday, July 17th. On Thursday, February 9 the insider Turner Heather D sold $192,067. 1,184 Atara Biotherapeutics Inc (NASDAQ:ATRA) shares with value of $18,056 were sold by Gallagher Carol Giltner. Clark Mitchall G. sold 3,059 shares worth $48,822. Therefore 43% are positive. The company's 50-day moving average price is $14.09 and its 200-day moving average price is $15.97. Lumentum had 33 analyst reports since August 4, 2015 according to SRatingsIntel. HSBC upgraded Constellation Brands, Inc. The rating was downgraded by KeyBanc Capital Markets on Thursday, October 29 to "Sector Weight". The Company's OpComms products include a range of components, modules and subsystems to support and maintain clients in its two primary markets: Telecom and Datacom. As per Wednesday, August 12, the company rating was maintained by Stifel Nicolaus. Stifel Nicolaus maintained the stock with "Buy" rating in Friday, June 30 report. On Wednesday, August 5 the stock rating was initiated by Goldman Sachs with "Neutral". 120 funds opened positions while 617 raised stakes. Its up 13.54% from 4.60 million shares previously. Us Financial Bank De accumulated 0.02% or 42,338 shares. Manufacturers Life Ins Company The stated it has 16,456 shares. Alliancebernstein Ltd Partnership owns 76,919 shares for 0% of their portfolio. Raymond James And Assoc invested in 21,450 shares or 0% of the stock. Franklin Street Advisors Inc. Jnba reported 0% of its portfolio in Constellation Brands, Inc. 914 are held by Savings Bank Of Montreal Can. Kensico Cap Corp reported 15.51% in Constellation Brands, Inc. Scott And Selber invested in 2.23% or 22,630 shares. Moreover, Estabrook Cap Mngmt has 0% invested in Chevron Corporation (NYSE:CVX). Nationwide Fund reported 0% of its portfolio in Atara Biotherapeutics Inc (NASDAQ:ATRA). Rhumbline Advisers has 27,350 shares for 0% of their portfolio. Its up 0.38, from 1.48 in 2016Q3. STZ's profit will be $426.29M for 22.86 P/E if the $2.16 EPS becomes a reality. Analysts expect next quarter's EPS to be $-0.99 with next year's EPS anticipated to be $-4.13.

Constellation Brands, an worldwide beverage alcohol company.

On March 9 JMP Securities made no change to the company rating of "Market Outperform" but lowered the price expectation from $40.00 to $34.00. The Company's divisions include Beer, Wine and Spirits, and Corporate Operations and Other.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

D'autres rapports CampDesrEcrues

Discuter de cet article